Aprikinin 125mg/80mg Capsule
Marketer
Miracalus Pharma Pvt Ltd
Salt Composition
Aprepitant (125mg) + Aprepitant (80mg)
Overview Aprikinin 125mg/80mg Capsule
Navirka 125mg/80mg capsules are a prescription medication for chemotherapy-induced nausea and vomiting. It works by blocking the signals to the brain that trigger these symptoms. Navirka 125mg/80mg capsules are administered as directed by your physician, with or without food. Dosage depends on your individual response and condition; complete the prescribed course. Premature discontinuation may lead to symptom recurrence and condition worsening. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects include constipation, indigestion, headache, fatigue, decreased appetite, and hiccups; most are transient. Report any concerning side effects promptly to your doctor. Drowsiness and dizziness may occur; avoid driving or activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Before starting treatment, disclose any pregnancy, pregnancy plans, or breastfeeding to your physician.
Uses of Aprikinin 125mg/80mg Capsule
Chemotherapy-induced emesis
Major Benefits of Aprikinin 125mg/80mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Aprikinin 125mg/80mg Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.
Common Side effects of Aprikinin 125mg/80mg Capsule:
- Constipation
- Indigestion
- Headache
- Tiredness
- Loss of appetite
- Hiccup
- Increased liver enzymes
How to use Aprikinin 125mg/80mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Aprikinin 125mg/80mg Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.
How Aprikinin 125mg/80mg Capsule works:
Each Aprepitant capsule of Aprikinin (125mg/80mg) contains a dual dose formulation. This medication counteracts a neurotransmitter responsible for chemotherapy-induced nausea and vomiting.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Aprikinin 125mg/80mg Capsules may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Aprikinin 125mg/80mg Capsule use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The use of Aprikinin 125mg/80mg capsules while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking an Aprikinin 125mg/80mg capsule might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Aprikinin 125mg/80mg capsules without requiring a dosage alteration.
LiverSAFE IF PRESCRIBED
The use of Aprikinin 125mg/80mg capsules in patients with liver impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Aprikinin 125mg/80mg Capsule :
Should you forget to take your Aprikinin 125mg/80mg Capsule, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Aprikinin 125mg/80mg Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
3,018 People bought this recently